SHAPING A FUTURE WITHOUT ACUTE RESPIRATORY DISEASE
SIME Diagnostics is a global Medtech company headquartered in London. SIME was founded in 2014 based on an invention by an award winning mathematician and a world renowned neonatologist, with the goal of revolutionising medicine by predicting respiratory disease in minutes at the point-of-care.
Professor Agnar Hoskuldsson knew his machine learning method, developed for the process industry, was the key to predicting disease before symptoms. Professor Henrik Verder, a world-renowned medical innovator who set the gold standard of care for neonatal respiratory disease, knew that the only way to reduce the mortality and morbidity in premature babies was to treat preventatively at birth.
By converging data science, technology and medicine, they invented a first of its kind Clinical AI Platform composed of a compact device, reagent-free disposable and AI. Multiple clinical trials followed, substantiating the platform as one of the most promising prognostic tools in acute respiratory care.